BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26183791)

  • 1. Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation.
    Proietti M; Marra AM; Tassone EJ; De Vuono S; Corrao S; Gobbi P; Perticone F; Corazza GR; Basili S; Lip GY; Violi F; Raparelli V; ;
    Am J Cardiol; 2015 Sep; 116(6):877-82. PubMed ID: 26183791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between carotid intima-media thickness and non valvular atrial fibrillation type.
    Proietti M; Calvieri C; Malatino L; Signorelli S; Corazza GR; Perticone F; Vestri AR; Loffredo L; Davì G; Violi F; Basili S;
    Atherosclerosis; 2015 Feb; 238(2):350-5. PubMed ID: 25555267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study.
    Violi F; Davì G; Proietti M; Pastori D; Hiatt WR; Corazza GR; Perticone F; Pignatelli P; Farcomeni A; Vestri AR; Lip GY; Basili S;
    Thromb Haemost; 2016 Apr; 115(4):856-63. PubMed ID: 26740316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of left ventricular hypertrophy, atrial fibrillation and cardiovascular disease in hypertensive patients of Andalusia, Spain. PREHVIA study].
    Martín-Rioboó E; García Criado E; Pérula De Torres LA; Cea-Calvo L; Anguita Sánchez M; López Granados A; Ureña Fernández T; García Matarín L; Molina Díaz R;
    Med Clin (Barc); 2009 Feb; 132(7):243-50. PubMed ID: 19248873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey).
    Erküner Ö; Dudink EAMP; Nieuwlaat R; Rienstra M; Van Gelder IC; Camm AJ; Capucci A; Breithardt G; LeHeuzey JY; Lip GYH; Crijns HJGM; Luermans JGLM
    Am J Cardiol; 2018 Aug; 122(4):578-583. PubMed ID: 29958714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
    Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
    Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hypertension with or without diabetes on left ventricular remodeling in rural Chinese population: a cross-sectional study.
    Li T; Chen S; Guo X; Yang J; Sun Y
    BMC Cardiovasc Disord; 2017 Jul; 17(1):206. PubMed ID: 28750662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study).
    Verdecchia P; Reboldi G; Di Pasquale G; Mazzotta G; Ambrosio G; Yang S; Pogue J; Wallentin L; Ezekowitz MD; Connolly SJ; Yusuf S;
    Am J Cardiol; 2014 Feb; 113(4):669-75. PubMed ID: 24359765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study.
    Watabe D; Hashimoto J; Hatanaka R; Hanazawa T; Ohba H; Ohkubo T; Kikuya M; Totsune K; Imai Y
    Am J Hypertens; 2006 Dec; 19(12):1199-205. PubMed ID: 17161763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network).
    Gerdts E; Izzo R; Mancusi C; Losi MA; Manzi MV; Canciello G; De Luca N; Trimarco B; de Simone G
    Int J Cardiol; 2018 May; 258():257-261. PubMed ID: 29544940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).
    Lønnebakken MT; Izzo R; Mancusi C; Gerdts E; Losi MA; Canciello G; Giugliano G; De Luca N; Trimarco B; de Simone G
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
    Raparelli V; Pastori D; Pignataro SF; Vestri AR; Pignatelli P; Cangemi R; Proietti M; Davì G; Hiatt WR; Lip GYH; Corazza GR; Perticone F; Violi F; Basili S;
    Intern Emerg Med; 2018 Aug; 13(5):651-660. PubMed ID: 29582316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in the prevalence of left ventricular hypertrophy within Germany.
    Völzke H; Stritzke J; Kuch B; Schmidt CO; Lüdemann J; Döring A; Schunkert H; Hense HW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):392-400. PubMed ID: 19369877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum uric acid level and left ventricular hypertrophy in elderly male patients with nonvalvular atrial fibrillation.
    Liang WY; Liu WW; Liu ML; Xiang W; Feng XR; Huang B; Chen XH; Sun YS
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):575-580. PubMed ID: 27162100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular hypertrophy in nondiabetic predialysis CKD.
    Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
    Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression is associated with increased occurrence of left ventricle concentric geometry in older subjects independently of blood pressure levels.
    Scuteri A; Castello L; Coluccia R; Modestino A; Nevola E; Volpe M
    Nutr Metab Cardiovasc Dis; 2011 Dec; 21(12):915-21. PubMed ID: 20674315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular geometry and outcomes in patients with atrial fibrillation: the AFFIRM Trial.
    Apostolakis S; Sullivan RM; Olshansky B; Lip GY
    Int J Cardiol; 2014 Jan; 170(3):303-8. PubMed ID: 24315343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-wave axis deviation and left ventricular hypertrophy interaction in diabetes and hypertension.
    Assanelli D; Di Castelnuovo A; Rago L; Badilini F; Vinetti G; Gianfagna F; Salvetti M; Zito F; Donati MB; de Gaetano G; Iacoviello L;
    J Electrocardiol; 2013; 46(6):487-91. PubMed ID: 24011993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.